Overexpression of AKR1C1 could promote bladder cancer cell lines to resist THP-induced apoptosis, while inhibition of AKR1C1 could make bladder cancer cells more susceptible to THP treatment and apoptosis. Here, AKR1C1 is linked to urinary bladder cancer.